Literature DB >> 8435878

Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.

E A Masson1, S L Atkin, M Diver, M C White.   

Abstract

Pituitary apoplexy has been reported as a rare complication of combined tests and of TRH administration in prolactinomas. A 54-year-old man with a pituitary macroadenoma had a single injection of 100 micrograms GnRH. Twenty minutes later he complained of increasing headache and vomited. These symptoms settled spontaneously and were attributed to the pharmacological effects of GnRH. Five hours later he was found to be blind and disorientated without spontaneous complaint. Emergency CT showed a large adenoma with central necrosis, consistent with pituitary apoplexy. An urgent surgical decompression was carried out and necrotic haemorrhagic debris removed. Baseline bloods revealed non-pulsatile FSH of 40 U/l with LH 0.3 U/l with no hormonal response to GnRH administration, but the sequence of events strongly suggests a causal relationship between this and pituitary apoplexy. To our knowledge this is the first time that GnRH administration has been associated with pituitary apoplexy of a glycoprotein secreting pituitary adenoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435878     DOI: 10.1111/j.1365-2265.1993.tb00980.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Choosing the best pre-operative management for large pituitary adenomas. Emerging questions.

Authors:  M Faustini-Fustini; A Goldoni; F Roncaroli; G Frank
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

Review 2.  Neurology of the pituitary gland.

Authors:  J R Anderson; N Antoun; N Burnet; K Chatterjee; O Edwards; J D Pickard; N Sarkies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

3.  Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.

Authors:  H S Dökmetaş; A Selçuklu; R Colak; K Unlühizarci; F Bayram; F Keleştimur
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

4.  Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.

Authors:  L Foppiani; S Piredda; R Guido; R Spaziante; M Giusti
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

5.  Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.

Authors:  Y Reznik; F Chapon; N Lahlou; N Deboucher; J Mahoudeau
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

6.  Clomiphene-induced pituitary apoplexy in a patient with acromegaly.

Authors:  A B Walker; P R Eldridge; I A MacFarlane
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

7.  Pituitary apoplexy associated with endocrine stimulation test: endocrine stimulation test, treatment, and outcome.

Authors:  Takahiro Yamamoto; Shigetoshi Yano; Jun-Ichiro Kuroda; Yu Hasegawa; Takuichiro Hide; Jun-Ichi Kuratsu
Journal:  Case Rep Endocrinol       Date:  2012-08-15

8.  Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions.

Authors:  Sladjana Dukic-Stefanovic; Jan Walther; Sebastian Wosch; Gerolf Zimmermann; Peter Wiedemann; Henry Alexander; Thomas Claudepierre
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.